HLA-G expression in non-small cell lung cancer was correlated with lymph nodal metastasis, clinical stages of the disease, and host immune response.Patients with HLA-G positive tumors had a shorter survival time than those with tumors that were HLA-G negativeHLA-G exhibited an independent prognostic factor. This evidence concerns the gene HLA-G and non-small cell lung carcinoma.